IL121170A0
(en )
1997-11-20
Compositions for the treatment of dermatological disorders
HUP9702244A3
(en )
1999-12-28
Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders
HUP0103856A3
(en )
2003-11-28
Pharmaceutical composition for the treatment of acute disorders
HUP9903166A3
(en )
2003-09-29
Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
IL124882A0
(en )
1999-01-26
Use of 3, 4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of menopausal symptoms
AU1367397A
(en )
1997-08-01
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes
IL117656A0
(en )
1996-07-23
Pharmaceutical compositions for the treatment of travellers diarrhea
HUP9702246A3
(en )
1999-12-28
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of degenerative cerebral disorders
HUP9800334A3
(en )
1999-12-28
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity
IL117655A0
(en )
1996-07-23
Pharmaceutical compositions for the treatment of travellers diarrhea
IL116745A0
(en )
1996-05-14
Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
EP0852503A4
(en )
1999-02-10
Composition for the treatment of diarrhea, its use and its preparation
AU5627796A
(en )
1997-01-09
Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury
AU4329196A
(en )
1996-08-07
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
IL116747A
(en )
1999-11-30
Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment of gynaecomastia
ZA96446B
(en )
1996-09-10
Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity
ZA98682B
(en )
1998-07-29
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders
ZA96440B
(en )
1996-09-10
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
ZA96248B
(en )
1996-11-07
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia
ZA96439B
(en )
1996-09-10
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of cerebral degenerative disorders
ZA97170B
(en )
1997-09-09
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of menopausal symptoms.
ZA97168B
(en )
1997-07-16
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment of prophylaxis of prostatic carcinoma
AU2003200309A1
(en )
2003-04-17
Pharmaceutical Composition for Preventing or Treating Ischaemic Diseases
ZA97167B
(en )
1997-07-18
Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of benign prostatic hypertrophy
ZA981918B
(en )
1998-09-14
Use of 2,3,4,5-tetrahydro-1H-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders